The global insufflation devices market size was exhibited at USD 2.71 billion in 2025 and is projected to hit around USD 5.59 billion by 2035, growing at a CAGR of 7.5% during the forecast period of 2026 to 2035.
The Insufflation Devices Market has become an indispensable part of minimally invasive surgeries, where the creation of a working space within body cavities is essential. Insufflation devices are used to introduce gases, typically carbon dioxide, into the abdominal cavity during procedures like laparoscopy, bariatric surgeries, and cardiac surgeries. This controlled inflation allows for better visualization, manipulation of organs, and access during surgical interventions.
The growth of the insufflation devices market is driven by the rising adoption of minimally invasive surgical techniques, an increasing burden of chronic diseases requiring surgical intervention, and technological advancements that enhance patient safety and surgical efficiency. Insufflation devices now offer features like pressure regulation, gas heating, and humidification, significantly improving patient outcomes and reducing postoperative complications.
Leading companies like Stryker Corporation, Karl Storz GmbH, and Olympus Corporation are investing in the development of next-generation insufflators equipped with intelligent control mechanisms, wireless connectivity, and user-friendly interfaces. The future of this market is closely tied to the expansion of laparoscopic procedures, the aging population, and the ongoing evolution of surgical technologies.
AI and ML are revolutionizing the insufflation devices industry by transitioning hardware toward intelligent, software-defined systems. Machine learning algorithms enable insufflators to predict surgical phase transitions and preemptively adjust gas pressure to prevent dangerous spikes. These smart devices also integrate with connected operating room dashboards and support predictive maintenance, minimizing equipment downtime. By optimizing gas flow and enabling continuous smoke evacuation, AI-assisted insufflators, such as the AirSeal iFS, significantly reduce post-operative complications and patient recovery times.
Integration of Intelligent Insufflation Systems: Smart insufflators with automated pressure and flow adjustments.
Rise in Demand for Heated and Humidified Insufflation: Reducing postoperative pain and enhancing recovery.
Growth in Bariatric and Cardiac Minimally Invasive Surgeries: Expanding use of insufflation across diverse surgical fields.
Shift Toward Disposable and Single-Use Insufflation Devices: Enhancing infection control.
Adoption of Robotic-Assisted Laparoscopic Surgeries: Driving the need for precise and integrated insufflation systems.
Expansion into Emerging Markets: Increasing healthcare infrastructure development fueling device adoption.
Focus on Reducing Insufflation-Related Complications: Innovations to manage gas embolisms and cardiovascular effects.
| Report Coverage | Details |
| Market Size in 2026 | USD 2.91 Billion |
| Market Size by 2035 | USD 5.59 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 7.5% |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Segments Covered | Application, End Use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Fujifilm; Medtronic; Stryker; BD; Olympus; B. Braun Melsungen; Smith & Nephew; Karl Storz; Steris; CONMED; Richard Wolf |
Rising Adoption of Minimally Invasive Surgeries Globally
The escalating preference for minimally invasive surgeries (MIS) is a major driver for the insufflation devices market. MIS techniques offer several advantages over traditional open surgeries, including reduced hospital stays, minimal scarring, faster recovery, and lower postoperative pain. According to a report published by the Society of American Gastrointestinal and Endoscopic Surgeons in March 2024, laparoscopic procedures accounted for over 65% of all general surgeries performed in developed economies, underscoring the strong momentum behind this trend. Insufflation devices are critical enablers of MIS, thereby directly benefiting from its growing adoption.
Risks Associated with Insufflation Procedures
Despite their advantages, insufflation devices can be associated with complications such as gas embolisms, hypercapnia, and adverse hemodynamic effects, particularly in high-risk patients. These risks, although relatively rare with modern systems, can discourage some surgeons and institutions from widespread adoption, especially in cardiac and critical care settings. Moreover, device malfunctions or user errors during insufflation can lead to serious intraoperative complications, highlighting the importance of rigorous training and device reliability.
Emergence of Advanced Heated and Humidified Insufflation Systems
A significant opportunity in the market lies in the development and commercialization of insufflation devices offering heated and humidified gas delivery. Traditional cold, dry gas insufflation can cause peritoneal desiccation, hypothermia, and postoperative pain. Newer devices that warm and humidify CO₂ before insufflation help maintain core body temperature, reduce inflammation, and improve patient comfort. In February 2024, a major clinical trial published by the American Journal of Surgery reported a 30% reduction in postoperative pain scores among patients who underwent heated, humidified gas insufflation compared to conventional methods.
Laparoscopic Surgery dominated the application segment in 2025. Laparoscopy, used across general surgery, gynecology, urology, and oncology, represents the largest share due to its widespread adoption, technological advancements, and surgeon familiarity. Insufflation devices designed for laparoscopy are becoming more sophisticated, integrating feedback mechanisms to maintain optimal intra-abdominal pressures without manual adjustments. This application benefits from a growing global trend toward day surgeries and cost-efficient surgical procedures.
Bariatric Surgery is the fastest-growing application segment. With global obesity rates continuing to rise, bariatric procedures like laparoscopic sleeve gastrectomy and gastric bypass are seeing unprecedented demand. Insufflation devices adapted for bariatric patients who often require higher flow rates and greater pressure regulation are becoming a focus area for manufacturers. In March 2024, the World Obesity Federation reported a 15% annual growth rate in bariatric surgeries worldwide, directly boosting the insufflation device market.
Hospitals dominated the end-use segment. Most laparoscopic and bariatric surgeries are conducted in hospitals due to the need for comprehensive perioperative care, intensive monitoring, and access to emergency services. Hospitals typically invest in premium insufflation devices equipped with multiple safety features, enabling a broader range of complex surgeries.
Ambulatory Surgical Centers (ASCs) are the fastest-growing end-use segment. ASCs focus on outpatient surgeries with rapid turnaround times, and their rising popularity is driving demand for compact, cost-effective insufflation devices. Increasing insurer support for same-day surgeries and patients’ preference for lower-cost alternatives to hospitals are reinforcing ASC growth. In January 2024, a major ASC network in the U.S. announced plans to equip all its facilities with next-gen portable insufflation units to support an expanding list of laparoscopic procedures.
North America dominated the global insufflation devices market in 2025. High adoption rates of minimally invasive surgeries, advanced healthcare infrastructure, strong reimbursement frameworks, and ongoing technological innovation contribute to North America's market leadership. The U.S. particularly commands a large share due to its early adoption of laparoscopic techniques, large number of bariatric surgeries, and focus on patient safety protocols. In March 2025, the American College of Surgeons reported a continued rise in laparoscopic surgeries across major healthcare systems.
U.S. Insufflation Devices Market Trends
The U.S. surge in bariatric surgeries is driven by climbing global obesity rates, alongside a rapid end-user transition toward cost-effective ambulatory surgical centers for outpatient care. To optimize these minimally invasive procedures, the industry is shifting toward smart, heated, and humidified insufflation systems that automatically regulate pressure and prevent tissue desiccation.
Asia-Pacific is the fastest-growing region. Rapid improvements in healthcare infrastructure, rising middle-class populations, increased medical tourism, and growing awareness about the benefits of minimally invasive surgeries are fueling demand. Countries such as China, India, and South Korea are experiencing double-digit growth rates in laparoscopic procedures. In February 2024, the Indian Ministry of Health announced a national initiative to subsidize laparoscopic surgery training, further accelerating market expansion in the region.
China Insufflation Devices Market Trends
China’s rapid integration of high-margin technological features, including automated smoke evacuation and gas humidification, alongside the rising adoption of robotic-assisted surgery platforms. The expanding healthcare infrastructure across the region is driving an overall surge in surgical procedure volumes, particularly within emerging markets.
How did the Europe Experience Hold a Notable Share of the Insufflation Devices Market?
Europe’s advanced medical technologies and minimally invasive surgical care. The aginf demographic and a high regional prevalence of obesity and diabetes, which directly correlates to a rising number of bariatric and ahigh regional prevalence of obesity and diabeties, which directly correlates to a rising number of bariatric and general laparoscopic procedures. To optimize these complex surgeries, European providers are rapidly integrating smart insufflation systems equipped with automated smoke evacuation and gas humidification to enhance surgeon visibility and patient safety.
U.K. Insufflation Devices Market Trends
The U.K.’s surge in bariatric surgeries by rising obesity rates, which fuels the demand for high-flow systems that maintain a stable pneumoperitoneum during lengthy operations. The rapid transition toward advanced, precision, flow systems engineered to maintain low-pressure stability drastically reduces postoperative pulmonary complications and shortens hospital stays.
Fujifilm manufactures advanced endoscopic CO2regulators and insufflation pumps designed to safely maintain internal cavity pressure during gastrointestinal (GI) procedures.
Medtronic provides essential access instruments for laparoscopic surgery, such as specialized pneumoperitoneum (Veress) needles and radially expandable access sleeves. These sterile, single-use access needles are used prior to abdominal endoscopies to safely introduce and establish gas insufflation in the patient's body.
Stryker is a market leader in high-performance laparoscopic insufflators, offering all-in-one platforms that combine CO2delivery with integrated smoke evacuation, gas heating, and humidification.
BD supports the broader medical device and surgical environment by providing crucial safety components and fluid management accessories used alongside insufflation equipment.
Olympus develops intelligent insufflation systems that precisely monitor and regulate gas pressure during minimally invasive and endoscopic procedures to maintain a clear working space.
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has segmented the global Insufflation devices market.
Application
End-use
By Region
Insufflation Devices Market
Download Sample
Request Customization
Request Customization
Download Sample